• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家药品服务单位的职责与职能探索性研究:全球趋势及科特迪瓦、肯尼亚和尼泊尔的案例

An exploratory study of the mandate and functions of national pharmaceutical services units: global trends and the cases of Côte d'Ivoire, Kenya, and Nepal.

作者信息

Koduah Augustina, Kusu Ndinda, Ahimon Herodias, Brown Andrew, Njeru Nancy, Menge Tom, Ouattara Mahama, Upadhyay Nijan, Upadhyaya Madan Kumar, Jiha Melissa, Hodgson Robbie, Nfor Emmanuel, Aboagye-Nyame Francis, Hafner Tamara

机构信息

School of Pharmacy, University of Ghana, Accra, Ghana.

USAID Medicines, Technologies, and Pharmaceutical Services Program, Management Sciences for Health, Nairobi, Kenya.

出版信息

J Pharm Policy Pract. 2024 Dec 13;17(1):2430438. doi: 10.1080/20523211.2024.2430438. eCollection 2024.

DOI:10.1080/20523211.2024.2430438
PMID:39687746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11648141/
Abstract

BACKGROUND

National pharmaceutical services units (NPSUs) - organisational units within the central government usually responsible for pharmaceutical services and management - have an increasingly narrow mandate. Anecdotal evidence points to an increasing focus, almost exclusively, on logistics management, while pharmaceutical care and policy oversight have become fragmented. This study examined NPSUs' current functions and mandates, and proposed what should be the critical functions and roles of these units going forward.

METHODS

Using case studies of Côte d'Ivoire, Kenya and Nepal, the study relied on a literature review and in-depth interviews. We triangulated and synthesised the findings to identify NPSUs by level in the health ministry's hierarchy and reporting line, mandate, and function.

RESULTS

We identified medicine regulation, procurement and supply chain management, selection and rational use of medicines, and pharmacy practice regulation as four broad sets of functions that NPSUs commonly have as their mandate. A clear position in the Ministry of Health's hierarchical structure, the legal or administrative framework that mandates an NPSU's functions, and national pharmaceutical policies and regulations to guide the pharmaceutical sector are three critical factors for effective functioning. It is essential to have a legislative framework that at a minimum identifies one NPSU as responsible for pharmaceutical policy and governance, serving as the steward for the pharmaceutical system. This role encompasses pharmaceutical system coordination and administrative functions, formulating and implementing policies for organising, managing, financing, regulating, monitoring, and evaluating the pharmaceutical system. As such, we recommend that NPSUs should at a minimum have four broad sets of functions: pharmaceutical policy and governance, medicine regulation, pharmacy practice regulation and procurement and supply chain management.

CONCLUSION

The study substantiates the need for a pharmaceutical policy and governance unit that stewards the pharmaceutical system and is empowered to monitor and evaluate system performance and coordinate efforts for system strengthening.

摘要

背景

国家药品服务单位(NPSUs)——中央政府内通常负责药品服务和管理的组织单位——的职责范围日益狭窄。传闻证据表明,几乎完全越来越侧重于物流管理,而药品照护和政策监督已变得分散。本研究考察了国家药品服务单位目前的职能和职责,并提出了这些单位未来应具备的关键职能和作用。

方法

该研究以科特迪瓦、肯尼亚和尼泊尔的案例研究为基础,依靠文献综述和深入访谈。我们对研究结果进行三角互证和综合分析,以按卫生部层级中的级别、报告线路、职责和职能来确定国家药品服务单位。

结果

我们确定药品监管、采购与供应链管理、药品的选择与合理使用以及药房业务监管为国家药品服务单位通常作为其职责的四大类职能。在卫生部层级结构中的明确地位、规定国家药品服务单位职能的法律或行政框架以及指导药品部门的国家药品政策和法规是有效运作的三个关键因素。必须有一个立法框架,至少确定一个国家药品服务单位负责药品政策和治理,充当药品系统的管理者。这一角色包括药品系统协调和行政职能,制定和实施用于组织、管理、资助、监管、监测和评估药品系统的政策。因此,我们建议国家药品服务单位至少应具备四大类职能:药品政策和治理、药品监管、药房业务监管以及采购与供应链管理。

结论

该研究证实需要设立一个药品政策和治理单位,以管理药品系统,并有权监测和评估系统绩效以及协调加强系统的工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993f/11648141/953d433e59ce/JPPP_A_2430438_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993f/11648141/953d433e59ce/JPPP_A_2430438_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993f/11648141/953d433e59ce/JPPP_A_2430438_F0001_OC.jpg

相似文献

1
An exploratory study of the mandate and functions of national pharmaceutical services units: global trends and the cases of Côte d'Ivoire, Kenya, and Nepal.国家药品服务单位的职责与职能探索性研究:全球趋势及科特迪瓦、肯尼亚和尼泊尔的案例
J Pharm Policy Pract. 2024 Dec 13;17(1):2430438. doi: 10.1080/20523211.2024.2430438. eCollection 2024.
2
The role of health system context in the design and implementation of performance-based financing: evidence from Cote d'Ivoire.卫生系统背景在绩效激励型融资的设计和实施中的作用:来自科特迪瓦的证据。
BMJ Glob Health. 2020 Sep;5(9). doi: 10.1136/bmjgh-2020-002934.
3
Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.埃塞俄比亚的药品监管框架:对其法律基础与实施情况的批判性评估
Ethiop J Health Sci. 2016 May;26(3):259-76. doi: 10.4314/ejhs.v26i3.9.
4
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.披露、透明和问责制:世界卫生组织东南亚区域公立部门药物委员会利益冲突政策的定性调查。
Global Health. 2022 Mar 18;18(1):33. doi: 10.1186/s12992-022-00822-8.
5
Patients Access to Medicines - A Critical Review of the Healthcare System in Kenya.患者获取药品——肯尼亚医疗体系的批判性审视
Risk Manag Healthc Policy. 2022 Mar 1;15:361-374. doi: 10.2147/RMHP.S348816. eCollection 2022.
6
National health policies: sub-Saharan African case studies (1980-1990).国家卫生政策:撒哈拉以南非洲案例研究(1980 - 1990年)
Soc Sci Med. 1999 Jul;49(2):223-39. doi: 10.1016/s0277-9536(99)00110-0.
7
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.一种新方法来收集药品市场数据以支持政策实施和药品可及性:以赞比亚的抗疟药品为例。
Malar J. 2018 Nov 29;17(1):444. doi: 10.1186/s12936-018-2594-9.
8
Meeting the reproductive health needs of female sex workers in Côte d'Ivoire: protecting the human right to dignified health.满足科特迪瓦性工作者的生殖健康需求:保护有尊严的健康权。
Reprod Health. 2023 Sep 5;20(1):133. doi: 10.1186/s12978-023-01659-z.
9
First Field Test of the Novel Integration Mapping Tool for COVID-19 Vaccination Integration into National Immunization Programs and Primary Healthcare-A Case Study from Côte d'Ivoire.将新冠疫苗接种纳入国家免疫规划和初级卫生保健的新型整合映射工具的首次现场测试——来自科特迪瓦的案例研究
Vaccines (Basel). 2023 Dec 12;11(12):1842. doi: 10.3390/vaccines11121842.
10
Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.儿童基本癌症药物的获取情况:东非供应情况、价格和卫生系统决定因素的比较混合方法分析。
Lancet Oncol. 2023 May;24(5):563-576. doi: 10.1016/S1470-2045(23)00072-4. Epub 2023 Apr 3.

本文引用的文献

1
Making the investment case for national regulatory authorities.为国家监管机构阐述投资理由。
J Pharm Policy Pract. 2021 Jan 21;14(1):16. doi: 10.1186/s40545-021-00299-7.
2
The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist.医院和社区药剂师在新冠疫情管理中的作用:迈向对药剂师角色、职责和义务的扩展定义
Pharmacy (Basel). 2020 Aug 7;8(3):140. doi: 10.3390/pharmacy8030140.
3
Pharmacists' viewpoint towards their professional role in healthcare system: a survey of hospital settings of Pakistan.
药剂师对其在医疗保健系统中专业角色的看法:对巴基斯坦医院环境的调查。
BMC Health Serv Res. 2020 Jul 2;20(1):610. doi: 10.1186/s12913-020-05459-0.
4
Perceptions and trends in the use of community pharmacies in Ghana.加纳社区药房使用情况的认知与趋势
J Pharm Policy Pract. 2019 Sep 18;12:25. doi: 10.1186/s40545-019-0186-x. eCollection 2019.
5
The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries.健康权作为全民健康覆盖的基础:71 个国家的国家药品政策跨国分析。
PLoS One. 2019 Jun 28;14(6):e0215577. doi: 10.1371/journal.pone.0215577. eCollection 2019.
6
Pharmaceutical services in the primary health care of the Brazilian Unified Health System: advances and challenges.巴西统一卫生系统初级卫生保健中的药学服务:进展与挑战。
Rev Saude Publica. 2017 Nov 13;51(suppl 2):3s. doi: 10.11606/S1518-8787.2017051007146.
7
Access to medicines: relations with the institutionalization of pharmaceutical services.药品可及性:与药学服务机构化的关系
Rev Saude Publica. 2017 Nov 13;51(suppl 2):8s. doi: 10.11606/S1518-8787.2017051007138.
8
Defining pharmaceutical systems strengthening: concepts to enable measurement.界定药品系统强化:有助于衡量的概念
Health Policy Plan. 2017 May 1;32(4):572-584. doi: 10.1093/heapol/czw153.
9
Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development.制药政策 第1部分 药剂师参与政策制定面临的挑战。
J Pharm Policy Pract. 2015 Feb 10;8(1):4. doi: 10.1186/s40545-015-0027-5. eCollection 2015.
10
A stewardship approach to shaping the future of public health supply chain systems.主导公共卫生供应链系统未来的管理方法。
Glob Health Sci Pract. 2014 Oct 29;2(4):403-9. doi: 10.9745/GHSP-D-14-00123.